The vaccine candidate will be developed by the Osaka-based company’s subsidiary Medicago from a plant from the tobacco family by December 2021.
( read original story …)
The Japan News
The vaccine candidate will be developed by the Osaka-based company’s subsidiary Medicago from a plant from the tobacco family by December 2021.
( read original story …)